Catalyst Wire Dossier Catalyst Wire Dossier

Saphris

asenapine
Drug timelines are a Plus or Pro feature.

24 regulatory and trial events tracked for Saphris, covering 2009-08-13 to 2025-01-22. Get the full timeline:

Most recent: FDA Approved: SAPHRIS — Supplemental Application (Allergan, Inc.)

See pricing